29.04.2014
Sopharma Trading proposes BGN 0.23 gross DPS (POSITIVE)
Read more
Filters
29.04.2014
Sopharma Trading proposes BGN 0.23 gross DPS (POSITIVE)
29.04.2014
Elhim Iskra Q1’14 sales down 5% YoY; 9% drop expected for Q2’14 (NEGATIVE)
29.04.2014
Sopharma Q1’14 unconsolidated profit improves 11.2% on sale of investments (NEUTRAL)
29.04.2014
The audit of Sopharma reduces 2013 consolidated net profit by 5.3% (NEGATIVE)